| Financial Year |
March 31 2023 |
| Monetary Funds |
1,465,743,475.45 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
15,699,783.60 |
| Accounts Receivable |
489,314,510.21 |
| Advances to Suppliers |
1,839,858,553.37 |
| Other Receivables |
46,508,885.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
14,340,000.00 |
| Inventories |
4,033,696,958.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,490,118.54 |
| Total Current Assets |
8,727,576,355.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
219,280,735.16 |
| Investment Properties |
28,939,252.15 |
| Fixed Assetes |
16,316,597,407.96 |
| Under-construction Projects |
860,855,173.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,228,842,285.37 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
157,441,042.78 |
| Deferred Income Tax Assets |
689,373,914.02 |
| Other Non-Current Assets |
639,743,180.07 |
| Sub-Total of Non-Current Assets |
22,487,123,561.10 |
| Total Assets |
31,214,699,916.85 |
| Short-Term Loans |
6,766,702,601.57 |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,971,764,823.89 |
| Accounts Payable |
5,977,563,247.35 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
156,414,894.65 |
| Taxes Payable |
27,416,558.21 |
| Interest Payable |
-- |
| Dividend Payable |
89,707,569.29 |
| Other payables |
529,797,919.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
392,029,966.74 |
| Other Current Liabilities |
286,220,905.64 |
| Sub-Total of Current Liabilities |
23,095,184,464.25 |
| Long-term Loans |
1,509,589,697.15 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,101,108,518.34 |
| Special Payable |
-- |
| Estimatied Liabilities |
18,077,573.22 |
| Deferred Income Tax Liabilities |
375,042,094.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,585,564,384.17 |
| Total Liabilities |
28,680,748,848.42 |
| Paid-In Capital(Or Share Stock) |
1,553,788,870.00 |
| Capital Surplus |
2,628,188,871.12 |
| Surplus Reserve |
797,067,452.60 |
| LESS:Treasury Stock |
68,522,480.00 |
| Undistributed Profits |
-2,458,511,255.89 |
| Minority Stockholder's Interest |
63,723,369.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,470,227,698.65 |
| Owner's Equity（Stockholder's Equity） |
2,533,951,068.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
31,214,699,916.85 |
